POST Online Media Lite Edition


CohBar appoints Joanne Yun as director

Christian Fernsby |
Menlo Park, Ca., USA - CohBar, a clinical stage biotechnology, announced the appointment of Joanne Yun as an independent director on the company’s board.

Article continues below

Dr. Yun is a partner at Egon Zehnder.

Dr. Yun leads the Research and Development segment of Egon Zehnder’s Health Practice.

Prior to joining Egon Zehnder, Dr. Yun was a Director in the Global Oncology Business Unit for Bayer HealthCare Pharmaceuticals with responsibility for oncology program management and new product planning.

Dr. Yun started her career with Bayer AG as a Bench Chemist and Laboratory Head in the Organic Synthesis Department of Bayer’s Central Research Division in Leverkusen, Germany.

She later transitioned into the Corporate Research and Development Planning Department for the Bayer AG Board of Management and then joined the Strategic Planning Department for the Pharmaceuticals Division, where she focused on global merger and acquisition strategies and transactions.

She subsequently transferred to Bayer’s North America Business Development and Licensing group.

Dr. Yun earned a bachelor’s degree in chemistry and French from Amherst College and a Ph.D. in chemistry from the Massachusetts Institute of Technology.